Torrent Pharmaceuticals is currently trading at RS. 3526.40, up by 22.05 points or 0.63% from its previous closing of RS. 3504.35 on the BSE.

The stock opened at RS. 3500.05 and recorded a high of RS. 3538.85 and a low of RS. 3500.05 during the session. So far, 3358 shares have been traded on the counter.

A BSE group 'A' stock with a face value of RS. 5, Torrent Pharma touched a 52-week high of RS. 3589.95 on October 10, 2024, and a 52-week low of RS. 2891.45 on March 3, 2025. Over the past week, the stock has fluctuated between a high of RS. 3545.00 and a low of RS. 3314.20. The company's current market capitalization stands at RS. 119337.55 crore.

Promoters hold 68.31% stake in the company, while institutions and non-institutions hold 24.66% and 7.03% respectively.

Torrent Pharmaceuticals has approached the Competition Commission of India (CCI) for approval to acquire a majority stake in J B Chemicals and Pharmaceuticals in a RS. 19,500-crore deal. Upon completion, Torrent Pharma will emerge as India’s second most valued pharmaceutical company. The proposed acquisition was first announced in June this year.

Torrent Pharmaceuticals, the flagship company of the Torrent Group, is a market leader in cardiovascular and central nervous system therapies. It also has a strong presence in gastro-intestinal, diabetology, anti-infective, and pain management segments.